Investor Presentation Evening..., page-45

First 45 Last

Share
Profile

Follow
rodad

478 Posts.

286

23/07/19

11:58

Post #: 39647611
Share

Originally posted by NZ Trader: ↑

Hi Lfc, actually given that significant thought along with a few other holders,, the short answer is No, No i dint think there is a necessity for additional cash. PAA raised additional cash beyond the K9 requirement, they raised more than enough for the K9 Phase II in the first round of the Rights Issue, the second tranche was quoted as additional and was to further Human MPL trials. Plus PAA just received an R and D rebate , as well as Epichem having every Hood being utilised and contracts renewed.
PAA recently paid down on their finance facility which now gives them $1.2m loan facility should it be required while Ink is Drying?

As in my post above,,I do not think the market has cottoned on here that Elanco could be knocking in 90 days..... so plenty of cash to tie us over till then.
The Investor evening is really to introduce PAA to the wider investment community, PAA Management are aware that the Scientific Gains made to date have not been recognised in the SP..
Management have a significant financial investment in this project to date ,,, this close to the finish further dilution would be a serious consideration..

Never say Never but I cant see it ,,Unless we get a ridiculous run up, then I think we all would be saying "now might be the time to CR@30/50c"

Also we have invested the greater amount on the preparation for the trial, new pills, writing the parameters for the Trial, filing , that's 3 months work done, PAA will have already fully budgeted the trial to completion,, they have to , to be able to meet the obligations of the trial patients..and gain ethics approval..
Distribution of medication and monitoring by local vet and data analysis ,, sounds easy in 11 words,,, Knock Knock ,, Elanco

Expand

Thanks NZ Trader, perfect summary!

PAA Price at posting: 6.1¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

AR3

Overland drilling proves promising for Australian Rare Earths' uranium hopes

Trump is President Again: What Does This Mean for Crypto?

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

CPV

ClearVue inks deal with UK heated glass player to combine solar tech with its offering

First 45 Last

Add NUZ (ASX) to my watchlist

(20min delay)
Last 20.0¢		Change 0.015(8.11%)		Mkt cap ! $98.34M

Open	High	Low	Value	Volume
19.0¢	20.0¢	19.0¢	$66.44K	346.2K

Buyers (Bids)

No.	Vol.	Price($)
3	86359	19.0¢

Sellers (Offers)

Price($)	Vol.	No.
20.0¢	107894	5

View Market Depth

No.	Vol.	Price($)
3	86359	0.190
14	839962	0.185
8	336753	0.180
4	120797	0.175
5	159661	0.170

Price($)	Vol.	No.
0.200	107894	5
0.205	109808	2
0.210	107676	2
0.215	154400	2
0.220	174409	3

Last trade - 15.42pm 13/11/2024 (20 minute delay)

NUZ (ASX) Chart

Investor Presentation Evening..., page-45

Overland drilling proves promising for Australian Rare Earths' uranium hopes

Trump is President Again: What Does This Mean for Crypto?

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

ClearVue inks deal with UK heated glass player to combine solar tech with its offering

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Investor Presentation Evening..., page-45

Top Stories

Overland drilling proves promising for Australian Rare Earths' uranium hopes

Trump is President Again: What Does This Mean for Crypto?

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

ClearVue inks deal with UK heated glass player to combine solar tech with its offering

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News